Literature DB >> 23065174

Role of MR imaging of uterine leiomyomas before and after embolization.

Sandeep P Deshmukh1, Carin F Gonsalves, Flavius F Guglielmo, Donald G Mitchell.   

Abstract

Leiomyoma, the most common uterine neoplasm, is composed of smooth muscle with varying amounts of fibrous connective tissue. Most leiomyomas are asymptomatic, but patients may present with abnormal uterine bleeding or bulk-related symptoms. Over the past decade, uterine fibroid embolization (UFE) has been an effective minimally invasive treatment for symptomatic patients. Magnetic resonance (MR) imaging is the most accurate imaging technique for detection and evaluation of leiomyomas and therefore has become the imaging modality of choice before and after UFE. As leiomyomas enlarge, they may outgrow their blood supply, resulting in various forms of degeneration that change their appearance. Leiomyomas are classified as submucosal, intramural, or subserosal. Submucosal and subserosal leiomyomas may be pedunculated, thus simulating other conditions. Understanding the MR imaging appearance of leiomyomas allows differentiation from other entities. The superior tissue contrast of MR imaging allows diagnosis of leiomyomas with a high level of confidence, ultimately leading to a decrease in the number of surgeries performed and thus reducing healthcare expenditures. MR imaging findings that influence the planning of UFE include the location, size, number, and vascular supply of leiomyomas. In addition, MR imaging can be used to assess the success of UFE and evaluate for potential complications. © RSNA, 2012.

Entities:  

Mesh:

Year:  2012        PMID: 23065174     DOI: 10.1148/rg.326125517

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  19 in total

1.  Three-Dimensional Quantitative Assessment of Uterine Fibroid Response after Uterine Artery Embolization Using Contrast-Enhanced MR Imaging.

Authors:  Julius Chapiro; Rafael Duran; MingDe Lin; John D Werner; Zhijun Wang; Rüdiger Schernthaner; Lynn Jeanette Savic; Mark L Lessne; Jean-François Geschwind; Kelvin Hong
Journal:  J Vasc Interv Radiol       Date:  2015-01-28       Impact factor: 3.464

2.  Structured vs narrative reporting of pelvic MRI for fibroids: clarity and impact on treatment planning.

Authors:  Andrea Franconeri; Jieming Fang; Benjamin Carney; Almamoon Justaniah; Laura Miller; Hye-Chun Hur; Louise P King; Roa Alammari; Salomao Faintuch; Koenraad J Mortele; Olga R Brook
Journal:  Eur Radiol       Date:  2017-12-15       Impact factor: 5.315

Review 3.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

Review 4.  Preprocedural MRI and MRA in planning fibroid embolization.

Authors:  Cristina Maciel; Yen Zhi Tang; Anju Sahdev; António Miguel Madureira; Paulo Vilares Morgado
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

5.  Uterine extension determined by MRI: a useful parameter for differentiating subserosal leiomyomas from ovarian tumors.

Authors:  Masaya Kawaguchi; Hiroki Kato; Yoshifumi Noda; Tatsuro Furui; Ken-Ichirou Morishige; Fuminori Hyodo; Masayuki Matsuo
Journal:  Abdom Radiol (NY)       Date:  2022-01-07

6.  Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization.

Authors:  Olivier Sutter; Philippe Soyer; Eimad Shotar; Raphael Dautry; Youcef Guerrache; Vinciane Placé; Raluca Opréa; Aude Ricbourg; Olivier Le Dref; Mourad Boudiaf; Marc Sirol; Anthony Dohan
Journal:  Eur Radiol       Date:  2016-01-22       Impact factor: 5.315

7.  How to differentiate benign from malignant myometrial tumours using MR imaging.

Authors:  Isabelle Thomassin-Naggara; Sophie Dechoux; Claire Bonneau; Audrey Morel; Roman Rouzier; Marie-France Carette; Emile Daraï; Marc Bazot
Journal:  Eur Radiol       Date:  2013-04-08       Impact factor: 5.315

8.  Quantitative perfusion histogram parameters of dynamic contrast-enhanced MRI to identify different pathological types of uterine leiomyoma.

Authors:  Subo Wang; Zhenhua Zhao; Yu Zhang; Liming Yang; Yanan Huang; Yawen Ruan; Cheng Wang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-02-25

9.  Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System.

Authors:  Fenfen Zhang; Yao Liu; Quan Quan; Yu Meng; Xiaoling Mu
Journal:  Cancer Manag Res       Date:  2021-06-14       Impact factor: 3.989

Review 10.  New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.

Authors:  Pamela Causa Andrieu; Sungmin Woo; Tae-Hyung Kim; Elizabeth Kertowidjojo; Anjelica Hodgson; Simon Sun
Journal:  Curr Opin Oncol       Date:  2021-09-01       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.